Yahoo Suche Web Suche

Suchergebnisse

1. Suchergebnisse:

1. www.annalsofoncology.org › article › S0923-7534(24)00676-8Renal cell carcinoma: ESMO Clinical Practice Guideline for...

   www.annalsofoncology.org › article › S0923-7534(24)00676-8

   Vor 4 Tagen · ESMO Clinical Practice Guideline (CPG) ESMO-MCBS. renal cell carcinoma. management. treatment. INCIDENCE AND EPIDEMIOLOGY. Renal cancer is the 14th most common malignancy worldwide, with >430 000 new cases diagnosed in 2020. 1 The incidence varies geographically, with higher incidence in Europe and North America.

2. www.cancer.gov › news-events › cancer-currents-blogAdjuvant Keytruda Improves Kidney Cancer Survival - NCI

   www.cancer.gov › news-events › cancer-currents-blog

   • Im Cache

   Vor 5 Tagen · The findings mark the first time a post-surgical, or adjuvant, treatment for kidney cancer has been shown to help people live longer. Based on earlier results from this trial, called KEYNOTE-564, the Food and Drug Administration (FDA) approved pembrolizumab in 2021 as an adjuvant treatment for kidney cancer.

3. www.nature.com › articles › s41585/024/00896-6Overall survival with adjuvant pembrolizumab in renal cell...

   www.nature.com › articles › s41585/024/00896-6

   17. Mai 2024 · In the KEYNOTE-564 trial, patients with resected clear cell renal cell carcinoma at a high risk of relapse experienced disease-free survival and especially overall survival benefits following...

4. medicalxpress.com › news › 2024-05-biomarker-successNew biomarker predicts success of immunotherapy in kidney cancer

   medicalxpress.com › news › 2024-05-biomarker-success

   • Im Cache

   Vor 2 Tagen · Their study, published in the journal Nature Medicine, also opens new avenues to even more effective treatments.. Every year, roughly 1,300 people in Austria are diagnosed with kidney cancer ...

5. www.nature.com › articles › s41585/024/00876-wVon Hippel–Lindau protein signalling in clear cell renal cell...

   www.nature.com › articles › s41585/024/00876-w

   2. Mai 2024 · Combination therapies with hypoxia signalling inhibitors plus other therapeutic agents hold potential for the treatment of advanced or metastatic ccRCC. Similar content being viewed by others....

6. www.kidneycancer.org › stories › new-research-1What’s New in Kidney Cancer Research

   www.kidneycancer.org › stories › new-research-1

   • Im Cache

   8. Mai 2024 · Adjuvant Therapy: Additional cancer treatment given after the primary treatment to lower the risk of the cancer coming back. Stereotactic Ablative Body Radiotherapy (SABR) : A highly precise form of radiation therapy aimed at destroying cancer cells while minimizing damage to surrounding healthy tissue.

7. www.nature.com › subjects › renal-cell-carcinomaRenal cell carcinoma - Latest research and news | Nature

   www.nature.com › subjects › renal-cell-carcinoma

   17. Mai 2024 · In the KEYNOTE-564 trial, patients with resected clear cell renal cell carcinoma at a high risk of relapse experienced disease-free survival and especially overall survival benefits following...